Department of Neurology, University Hospital Essen, Essen, Germany.
Arterioscler Thromb Vasc Biol. 2013 Jul;33(7):1561-7. doi: 10.1161/ATVBAHA.112.300749. Epub 2013 Apr 4.
Therapeutic angiogenesis aims at the promotion of vascular growth, usually under conditions of atherosclerosis. It was unknown how hyperlipidemia, a risk factor that is closely associated with atherosclerosis of brain vessels in humans, influences vascular endothelial growth factor-induced angiogenesis and stroke recovery.
Wild-type and apolipoprotein-E (ApoE)(-/-) mice were kept on regular or cholesterol-rich diet for mimicking different severities of hyperlipidemia. Mice were treated intracerebroventricularly with recombinant human vascular endothelial growth factor for 21 days (0.02 µg/d) and subsequently subjected to 90-minute middle cerebral artery occlusion followed by 1 or 24 hours of reperfusion. Histochemical, autoradiographic, and regional bioluminescence techniques were used to evaluate effects of blood lipids on postischemic angiogenesis, histopathologic brain injury, cerebral blood flow, protein synthesis and energy state, and pericyte coverage of brain endothelial cells. Hyperlipidemia dose-dependently attenuated vascular endothelial growth factor-induced capillary formation and pericyte coverage of brain endothelial cells, abolishing the improvement of cerebral blood flow during subsequent stroke, resulting in the loss of the metabolic penumbra and increased brain infarction. The enhanced angiogenesis after vascular endothelial growth factor treatment was accompanied by increased expression of the adhesion protein N-cadherin, which mediates endothelial-pericytic interactions, in ischemic brain microvessels of wild-type mice on regular diet that was blunted in wild-type mice on Western diet and ApoE(-/-) mice on either diet.
The compromised vessel formation and hemodynamics question the concept of therapeutic angiogenesis in ischemic stroke where hyperlipidemia is highly prevalent.
治疗性血管生成旨在促进血管生长,通常在动脉粥样硬化的情况下进行。目前尚不清楚高脂血症(一种与人类脑血管粥样硬化密切相关的危险因素)如何影响血管内皮生长因子诱导的血管生成和中风恢复。
野生型和载脂蛋白 E(ApoE)(-/-)小鼠分别接受普通饮食或富含胆固醇饮食,以模拟不同严重程度的高脂血症。用重组人血管内皮生长因子对小鼠进行侧脑室注射治疗 21 天(0.02μg/d),随后进行 90 分钟大脑中动脉闭塞,再进行 1 或 24 小时再灌注。采用组织化学、放射自显影和区域生物发光技术评估血脂对缺血后血管生成、组织病理学脑损伤、脑血流、蛋白质合成和能量状态以及脑内皮细胞周细胞覆盖的影响。高脂血症呈剂量依赖性地减弱血管内皮生长因子诱导的毛细血管形成和脑内皮细胞周细胞覆盖,从而取消了随后中风期间脑血流的改善,导致代谢半影区丧失和脑梗死增加。血管内皮生长因子治疗后的增强血管生成伴随着缺血性脑微血管中黏附蛋白 N-钙黏蛋白表达的增加,该蛋白介导内皮细胞-周细胞相互作用,而在普通饮食的野生型小鼠和任一种饮食的 ApoE(-/-)小鼠中,这种表达减弱。
在高脂血症高发的缺血性中风中,受损的血管形成和血液动力学对治疗性血管生成的概念提出了质疑。